IL6R and rheumatoid arthritis: Case series of patients with rheumatoid arthritis treated with tocilizumab found reductions in HbA1c following IL-6R inhibition58,59 and a meta-analysis of prospective studies showed significant associations between higher IL-6 levels and incident type 2 diabetes60.